Author(s):
Pranesh Prakash Gaikwad, Mamta Nakade, Santosh Kamble, Mayur Shiralkar, Vaishali Chaudhari, Mangesh Udmale
Email(s):
pranesh.gaikwad@dpu.edu.in
DOI:
10.52711/0974-360X.2023.00157 
Address:
Pranesh Prakash Gaikwad1, Mamta Nakade2, Santosh Kamble3, Mayur Shiralkar4, Vaishali Chaudhari5, Mangesh Udmale6
1Associate Professor (PhD Scholar), Panchakarma Department, Dr. D. Y. Patil College of Ayurved and Research Centre Pimpri, Pune, Dr. D. Y. Patil Vidyapeeth Pune (Deemed to be University)
2Professor, Panchakarma Department, Dr. D. Y. Patil College of Ayurved and Research Centre Pimpri, Pune,
Dr. D. Y. Patil Vidyapeeth Pune (Deemed to be University)
3Associate Professor (PhD Scholar), Swasthavritta Department, Dr. D. Y. Patil College of Ayurved and Research Centre Pimpri, Pune, Dr. D. Y. Patil Vidyapeeth Pune (Deemed to be University)
4Professor, Shalakyatantra Department, Dr. D. Y. Patil College of Ayurved and Research Centre Pimpri, Pune
Dr. D. Y. Patil Vidyapeeth Pune (Deemed to be University)
5Associate Professor (PhD Scholar), Panchakarma Department, Dr. D. Y. Patil College of Ayurved and Research Centre Pimpri, Pune
Dr. D. Y. Patil Vidyapeeth Pune (Deemed to
Published In:
Volume - 16,
Issue - 2,
Year - 2023
ABSTRACT:
Background: Almost a year to the pandemic situation gone, but still no approved scientific treatment only experimental cocktail for novel coronavirus disease. Ayurveda as a complementary medicine, claims the Ayurveda drug has strong immunity boosting and anti-inflammatory benefits against the coronavirus. To get a global recognition, AYUSH system encourages to carry a randomized controlled clinical trial to treat novel coronavirus disease. In this study, we aimed to summarize the effectiveness of Ayurveda interventions and which interventions are most effective in management of COVID19 positive patients. Methods: To ensure relative efficacy of Ayurveda interventions in management of COVID 19 positive patients, we will systematically search randomized controlled trials and quasi-randomised controlled trials in electronic databases. Also, we will search unpublish material from pre-print servers and grey literature. Two independent researchers will conduct the selection process based on inclusion and exclusion criteria according to PRISMA guidelines. Upon selection, we will carry out quality assessment with the help of GRADE and risk of bias assessment using Cochrane Collaboration’s Risk of Bias Assessment Tool. Using R-3.4.1 software to process and analyse data. Result: The results of this study will be published in a peer-reviewed journal. Discussion: The findings from this study will provide directions for further research and provide helpful evidence for clinicians to formulate best Ayurveda treatment strategy for management of COVID-19 positive patients. Systematic review registration: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42021267410.
Cite this article:
Pranesh Prakash Gaikwad, Mamta Nakade, Santosh Kamble, Mayur Shiralkar, Vaishali Chaudhari, Mangesh Udmale. Protocol for a Systematic review and Network meta-analysis of Randomized controlled trials examining the effectiveness of Ayurveda Interventions in management of Covid 19 positive patients. Research Journal of Pharmacy and Technology 2023; 16(2):936-0. doi: 10.52711/0974-360X.2023.00157
Cite(Electronic):
Pranesh Prakash Gaikwad, Mamta Nakade, Santosh Kamble, Mayur Shiralkar, Vaishali Chaudhari, Mangesh Udmale. Protocol for a Systematic review and Network meta-analysis of Randomized controlled trials examining the effectiveness of Ayurveda Interventions in management of Covid 19 positive patients. Research Journal of Pharmacy and Technology 2023; 16(2):936-0. doi: 10.52711/0974-360X.2023.00157 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-2-76
REFERENCES:
1. Thakar A, Panara K, Patel F, et al. Add-on Ayurveda Treatment for Early Stage COVID-19: A Single Center Retrospective Cohort Study From Gujarat, India. J Evidence-Based Integr Med. 2021;26:1-7. doi:10.1177/2515690X211020685
2. Shah I, Raytthatha N, Vyas DJ, Upadhyay DU. A Systematic Review on COVID 19 Treatment and Management. Res J Pharm Dos Forms Technol. 2021;13(3):230-238. doi:10.52711/0975-4377.2021.00039
3. India: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. Accessed August 8, 2021. https://covid19.who.int/region/searo/country/in
4. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-192. doi:10.1038/s41579-018-0118-9
5. Srikanth N, Rana R, Singhal R, et al. Mobile App–Reported Use of Traditional Medicine for Maintenance of Health in India During the COVID-19 Pandemic: Cross-sectional Questionnaire Study. JMIRx Med. 2021;2(2):1-13. doi:10.2196/25703
6. Schueller E, Klein E, Lin G, et al. COVID 19 in India: potential impact of the lockdown and other longer-term policies; publication of the Centre for disease dynamics, economics & policy, princeton university. y. https://cddep.org/wp-content/uploads/2020/04/India-Shutdown-Modeling-Slides-Final-2.pdf. https://cddep.org/publications/covid-19-india-potential-impact-of-the-lockdown-and-other-longer-term-policies/
7. Wanjarkhedkar P, Sarade G, Purandare B, Kelkar D. A prospective clinical study of an Ayurveda regimen in COVID 19 patients. J Ayurveda Integr Med. 2020;(xxxx). doi:10.1016/j.jaim.2020.10.008
8. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 2020;324(8):782-793. doi:10.1001/jama.2020.12839
9. Kataria S, Sharma P, Ram JP, et al. A Pilot Clinical study of an add on Ayurvedic formulation containing Guduchi and Pippali in mild to moderate Covid - 19. J Ayurveda Integr Med. Published online 2021. doi:10.1016/j.jaim.2021.05.008
10. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(4):1-23. doi:10.11855/j.issn.0577-7402.2020.01.01
11. Amrutia P, Dave D. Prevailing Tenor for Ayurveda in Views of Ayurvedic Practitioners. Asian J Manag. 2017;8(4):1029-1036. doi:10.5958/2321-5763.2017.00158.5
12. Meena AK, Meena J, Jadhav A, Padhi MM. A review on Hiptage benghalensis (Madhavilata) used as an Ayurvedic drug. Asian J Pharm Technol. 2014;4(1):28-31.
13. Pagar SA, Suryawanshi HK. Nanotechnology- Finding proofs for its ancient origin. Asian J Res Pharm Sci. 2021;11(1):65-70. doi:10.5958/2231-5659.2021.00011.4
14. Rastogi S, Pandey DN, Singh RH. COVID-19 pandemic: A pragmatic plan for ayurveda intervention. J Ayurveda Integr Med. doi:10.1016/j.jaim.2020.04.002
15. Sherekar P, Shinde NG. Ayurveda : A Need of Hours. Res J Pharmacogn Phytochem. 2019;11(04):229-230. doi:10.5958/0975-4385.2019.00039.6
16. Ministry of AYUSH Ayurveda’s immunity boosting measures for self care during COVID 19 crisis. New Delhi: M/o AYUSH. Published 2020.https://www.mohfw.go v.in/pdf/ImmunityBoostingAYUSHAdvisory.pdf.
17. Alankar S, Jain R, Agrawal RK, Ahirwar D. Clinical Trial of Herbal Drugs and Products in India : Past and Current Status and Critical Issues. Res J Pharm Technol. 2008;1(2):69-74.
18. Bhat BB, Udupa N, Sreedhar D. Knowledge and attitude of Ayurvedic Physicians towards Adverse drug reactions and reporting methods in Udupi region. Res J Pharm Technol. 2018;11(1):117-120. doi:10.5958/0974-360X.2018.00022.7
19. Kaushik S, Mehta A, Srivastava S, Mehendale S. Factors Affecting Employee Satisfaction – A Methodological and Thematic Review. Asian J Manag. 2018;09(01):834-840. doi:10.5958/2321-5763.2018.00132.4
20. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: Elaboration and explanation. BMJ. 2015;349(January):1-25. doi:10.1136/bmj.g7647
21. Higgins JPT, Thomas J, Chandler J, et Al., Ed. Cochrane Handbook for Systematic Reviews of Interventions Version 6.0. Cochrane. 2019. Available from: Www.Training.Cochrane.Org/Handbook.
22. Ahmad A, Rai AK, Negandhi H, Gundeti MS, Rao BCS, Srikanth N. Efficacy and Safety of Ayurveda Interventions as Standalone or Adjuvant Therapy in Management of COVID-19 : A Systematic Review Protocol Efficacy and Safety of Ayurveda Interventions as Standalone or Adjuvant Therapy in Management of COVID-19 : A Systemat. J Res Ayurvedic Sci. 2020;4(3):121-127. doi:10.5005/jras-10064-0112
23. Santos CM da C, Pimenta CA de M, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem. 2007;15(3):508-511. doi:10.1590/s0104-11692007000300023
24. Yugander P, Jagannath M. Structural Neuroimaging Findings in Autism Spectrum Disorder : A Systematic Review. Res J Pharm Technol. 2021;14(4):2341-2347. doi:10.52711/0974-360X.2021.00413
25. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010;8(5):336-341. doi:10.1016/j.ijsu.2010.02.007
26. Puhan MA, Schünemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349(September):1-10. doi:10.1136/bmj.g5630
27. Rani U, Lewis LE, Kothuri MS, Chawla K, Godinho MA, Ravishankar N. Factors Associated with Neonatal Healthcare-Associated Infections ( HAIs ) in India : A Protocol for Systematic Review and Meta-analysis. Res J Pharm Technol. 2020;13(4):1672-1678. doi:10.5958/0974-360X.2020.00303.0
28. JPT H, Green S. Cochrance Handbook for Systematic Reviews of Interventions Version 5.1.0 [EB/OL]. The Cochrane Collaboration, 2011 [2013.5.16]. Http://Www.Cochrane-Handbook.Org.
29. Chaimani A, Caldwell DM, Li T HJS. Undertaking Network Meta_analyses. In: Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (Updated July 2019) Cochrane, 2019. 2019.
30. Caldwell DM, Welton NJ. Approaches for synthesising complex mental health interventions in meta-analysis. Evid Based Ment Health. 2016;19(1):16-21. doi:10.1136/eb-2015-102275
31. Ge L, Tian J hui, Li L, Wang Q, Yang K hu. Mesh fixation methods in open inguinal hernia repair: a protocol for network meta-analysis and trial sequential analysis of randomised controlled trials. BMJ Open. 2015;5:e009369. doi:10.1136/bmjopen-2015-009369
32. G van V, Kuiper J, Gemtc: Network meta-analysis using Bayesian methods. Available at: http://cran.r-project.org/web/packages/ gemtcpdf(access date 21 July, 2021).
33. Daly CH, Neupane B, Beyene J, Thabane L, Straus SE, Hamid JS. Empirical evaluation of SUCRA-based treatment ranks in network meta- analysis : quantifying robustness using Cohen ’ s kappa. BMJ Open. 2019;9:e024625:1-11. doi:10.1136/bmjopen-2018-024625
34. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised. 2011;(fig 1):1-8. doi:10.1136/bmj.d4002
35. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing Risk of Bias in Included Studies. Higgins JPT, Green S (Eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1. 0. Cochrane Collaboration. 2016.
36. Boutron I, Page MJ, Higgins JPT, Altman DG, Lundh A, Hróbjartsson A et al. Considering Bias and Conflicts of Interest among the Included Studies. Cochrane Handb Syst Rev Interv. 2019:177–204.
37. Richardson M, Garner P, Donegan S. Interpretation of subgroup analyses in systematic reviews: A tutorial. Clin Epidemiol Glob Heal. 2019;7(2):192-198. doi:10.1016/j.cegh.2018.05.005
38. Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Assessing Risk of Bias in a Randomized Trial. Cochrane Handb Syst Rev Interv. 2019:205–28.